Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of selective serotonin reuptake inhibitors (SSRIs) and other neuromodulatory agents. The compound's fluorinated and methoxylated aromatic core enhances blood-brain barrier penetration, making it valuable in designing drugs for depression, anxiety, and neurodegenerative disorders. It is also employed in research settings to explore new bioactive molecules with improved metabolic stability and receptor affinity.